Abstract: Imidazo[1,2-f]phenanthridine compounds are provided. The compounds have a twisted aryl moiety further substituted by alkyl having four or more atoms. The compounds may be used in organic light emitting devices, particularly as emissive dopants, providing devices with improved efficiency, stability, and manufacturing. In particular, the compounds provided herein may be used in blue devices having high efficiency.

Abstract: The present invention concerns compositions and methods of extracting infectious pathogens from a volume of blood. In one embodiment, the method includes the steps of creating a fibrin aggregate confining the pathogens and introducing a fibrin lysis reagent to expose the pathogens for analysis. The present invention also concerns materials and methods for removing aurintricarboxylic acid (ATA) from a sample.

Abstract: A method is provided for purifying a protein comprising the steps of providing a heme tag with an open coordination site and tagging the recombinant protein of interest with the heme tag. A resin framework is used, wherein a base that binds to heme is immobilized to the resin, and the open coordination site of the heme tag is capable of reversibly binding to the base immobilized to the resin. The tagged protein is reversibly bound to the resin, then eluted from the resin and quantified. The method enables the tagged protein to be tracked during protein expression or purification, and can be used to identify secretion of a protein to the periplasm or to tag proteins in the cytoplasm.

Abstract: There are provided a novel compound having a good field mobility, a method of producing of the compound, an organic semiconductor material containing the novel compound, and an organic semiconductor device. The novel compound which is represented by the following general formula (1), (2), (3) or (4) (where Z represents a sulfur atom or a selenium atom, and R represents a hydrogen atom, an alkyl group or a phenyl group in general formulae) has a structure having two benzene rings of naphthalene bonded with a thiophene ring and a selenophene ring, respectively. These compounds have a conjugate system in molecules due to an interaction between ? orbitals, and show a strong molecular interaction through a sulfur atom or a selenium atom contained in a thiophene ring or a selenophene ring in each molecule, thereby having a good field mobility.

Abstract: A millimeter wave wireless (M2W2) interconnect is used for transmitting and receiving signals at millimeter-wave frequencies for short-range wireless communication with high data rate capability. The transmitter and receiver antennae may comprise an on-chip differential dipole antenna or a bond wire differential dipole antenna. The bond wire differential dipole antenna is comprised of a pair of bond wires connecting between a pair of pads on an integrated circuit (IC) die and a pair of floating pads on a printed circuit board (PCB).

Abstract: A method of preparing a digital medical image for secure transmission, the method comprising embedding data into the digital medical image using a reversible watermarking process, generating a code for tamper detection and localization from the digital medical image using a computational function, and embedding the code for tamper detection and localization into the digital medical image using the reversible watermarking process; and a method of reviewing a digital medical image prepared by the method of preparing, the method of reviewing comprising retrieving the code for tamper detection and localization from the digital medical image; reversing the watermarking processes to obtain a restored image; generating a code from the restored image using the computational function; and comparing the retrieved code for tamper detection and localization with the code generated from the restored image to detect and locate tampering.

Abstract: A method of authenticating a Personal Network Entity (PNE) is provided. The method includes transmitting a PNE serial number (SNPNE) to a CPNS (Converged Personal Network Service) server by a Personal Network GateWay (PN GW); storing an authentication value chain of a PNE transmitted from the CPNS server and an inherent assignment key (TKPNE) that is secret information of a corresponding PNE; encrypting a selected authentication value from among the authentication value chain with the inherent assignment key of the corresponding PNE to transmit the encrypted authentication value to the corresponding PNE and storing the encrypted authentication value in the corresponding PNE; and performing an authentication procedure between the corresponding PNE and the CPNS server by using the encrypted authentication value stored in the PNE.

Abstract: Provided herein are scaffolds and methods useful to promote the formation of functional clusters on a tissue, for example, motor endplates (MEPs) or a component thereof on skeletal muscle cells or tissue, as well as the use of scaffolds so produced for repairing a tissue injury or defect.

Abstract: The present invention relates to protein chips useful for the large-scale study of protein function where the chip contains densely packed reaction wells. The invention also relates to methods of using protein chips to assay simultaneously the presence, amount, and/or function of proteins present in a protein sample or on one protein chip, or to assay the presence, relative specificity, and binding affinity of each probe in a mixture of probes for each of the proteins on the chip. The invention also relates to methods of using the protein chips for high density and small volume chemical reactions. Also, the invention relates to polymers useful as protein chip substrates and methods of making protein chips. The invention further relates to compounds useful for the derivatization of protein chip substrates.

Abstract: A method of improving cognition in a patient with Down syndrome, which entails administering one or more ?2 adrenergic receptor agonists to the patient in an amount and with a frequency effective to improve cognition of the patient as measured by contextual learning tests

Abstract: Devices comprising multiple flexible substrates bearing OLEDs are provided. The flexible substrates are interconnected, and the properties of the substrates and the interconnections provide the shape of the device.

Abstract: The present disclosure relates to a method for heating an object. A sheet-shaped heat and light source is provided. The sheet-shaped heat and light source includes a carbon nanotube film curved to form a hollow cylinder, and at least two electrodes spaced from each other, located on a surface of the hollow cylinder and electrically connected to the carbon nanotube film. An object is located in the hollow cylinder. A voltage is supplied between the at least two electrodes.

Abstract: A metal iridium complexes, devices containing the same, and formulations including the same described.

Abstract: A system for the high-throughput screening of mechanical properties of cells and/or particles is provided. In certain embodiments the system comprises a first structure comprising a plurality of sample receiving wells; a second structure comprising a plurality of exit ports; a porous structure disposed between said plurality of sample receiving wells and said plurality of exit ports and in communication with said plurality of sample receiving wells and in communication with said plurality of exit ports, and said first structure, said second structure and said porous structure are sealed or configured such that when sufficient pressure is applied to sample receiving wells in said first structure said cells or particles migrate through the porous structure into said exit ports, and wherein the mean or the median pore size of said porous structure is smaller than the mean or median cross-section of a cell or particle that is to be screened.

Abstract: The present invention relates to shape memory polymers (SMP) and especially to shape memory polymer containing a water soluble non-reactive plasticiser and to uses thereof.

Abstract: Compositions and methods for the treatment of norovirus infection are disclosed.

Abstract: Genetically engineered cells and microorganisms are provided for preventing or ameliorating diseases through genetically engineered quorum signaling. Therapeutic methods for using the cells and microorganisms to prevent or ameliorate diseases are also provided. The genetically engineered cells or microorganisms can be engineered to express a signal and used to interrupt the signaling-dependent virulence of an invading pathogen. The cells or microorganisms can be used to provide signal-dependent expression of a desirable gene in order to interrupt, prevent, and/or ameliorate a disease of mammals, such as parasitic diseases, infectious diseases, autoimmune diseases and genetic disorders.

Abstract: The present disclosure generally relates to tyrosine phosphorylation sites of an Akt enhancer, and methods for the detection of the phosphorylated tyrosine residues. In particular, anti-phosphotyrosine antibodies and binding proteins find use in the compositions and methods of the present disclosure.

Abstract: A system, and a method for its use, provides for placement of a fluid delivery needle into the tail of a laboratory animal. The system includes an animal receiving portion, structure configured to receive, position and restrain a tail of the animal placed in the animal receiving portion and a hollow needle attached to a fluid transfer device. Positioning structure is provided to align the needle and fluid transfer chamber with the restrained tail for proper automated insertion of the needle into a blood vessel within the tail. A lateral actuator operatively connected to the fluid transfer device moves the hollow needle in a forward direction so that it is inserted into the blood vessel of the properly aligned tail. The system can include a computer programmed to automatically perform all of the functions and operate all the components of the system.

Abstract: Methods and compositions for treating acute suicidality by administration of buprenorphine are disclosed herein. An exemplary method is effected by administering to a subject determined as having acute suicidality a first therapeutically effective amount of buprenorphine, or a pharmaceutically acceptable salt thereof, whereby the administration is ceased once the subject is no longer determined as having acute suicidality. The first therapeutically effective amount is less than 0.2 mg per day. A higher therapeutically effective amount may optionally be administered if the subject is determined as not fully responsive to the first therapeutically effective amount. Unit dosage forms of buprenorphine, comprising less than 0.2 mg (e.g., 0.1 mg) buprenorphine are also disclosed.